Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.

Source:http://linkedlifedata.com/resource/pubmed/id/20368561

J. Clin. Oncol. 2010 May 1 28 13 2259-66

Download in:

View as

General Info

PMID
20368561